Connect
← Return to Transplant: No or Few Antibodies after COVID Vaccination
Discussion
Transplant: No or Few Antibodies after COVID Vaccination
Transplants | Last Active: Mar 7, 2022 | Replies (193)Comment receiving replies
This is good news -
An international phase III trial presented at the 2021 virtual IDWeek conference found that a 3-day course of intravenous remdesivir (Veklury) in COVID-19 outpatients at high risk of progression to severe disease significantly reduced the risk of hospitalization by 87% versus placebo
https://www.medpagetoday.com/meetingcoverage/idweekvideopearls/95391
Replies to "This is good news - An international phase III trial presented at the 2021 virtual IDWeek..."
Connect
Hi there. U r a wealth of info.thank God. How r u? I still have my dirreaha going on 5 months. Had a colonoscopy and endoscope two weeks ago still waiting for results. Dr. Took me off CellCept mayb culprit...feel like a prisoner can't go out. I got a job someone wants me! Part time In school co teach. But feel weak ..u all take care...